We are live on ! Find out more
MCM

Marsico Capital Management Portfolio holdings

AUM $3.4B
1-Year Est. Return 51.58%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$11.3B
AUM Growth
-$536M
Cap. Flow
-$722M
Cap. Flow %
-6.38%
Top 10 Hldgs %
44.21%
Holding
104
New
17
Increased
29
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$232M
2
EA icon
Electronic Arts
EA
+$162M
3
CRM icon
Salesforce
CRM
+$118M
4
BHC icon
Bausch Health
BHC
+$90.4M
5
ZTS icon
Zoetis
ZTS
+$87.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$265M
2
BIIB icon
Biogen
BIIB
+$215M
3
CP icon
Canadian Pacific Kansas City
CP
+$190M
4
UNP icon
Union Pacific
UNP
+$158M
5
BABA icon
Alibaba
BABA
+$148M

Sector Composition

Rank Sector Weight
1 Healthcare 29.72%
2 Communication Services 19.78%
3 Technology 14.98%
4 Consumer Discretionary 12.37%
5 Financials 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDQ
101
DELISTED
Novadaq Technologies Inc.
NVDQ
-394,726
Closed -$6.41M
PLKI
102
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
-183,559
Closed -$11M
RCPT
103
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
-51,132
Closed -$8.43M
TWC
104
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-519,237
Closed -$77.8M

Similar funds

Marsico Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Marsico Capital Management held 104 positions worth $11.3B, down 4.5% from $11.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Marsico Capital Management withdrew a net $722M in Q2 2015, closing 13 positions and reducing 44 holdings. Its most notable exit was Gilead Sciences, an estimated $265M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Marsico Capital Management opened a new position in Zoetis worth $88.2M.

  • Marsico Capital Management's largest Q2 2015 buy was Zoetis: 1,828,140 shares worth $88.2M.
  • Marsico Capital Management added most to Illumina in Q2 2015, an estimated $232M increase.
  • Marsico Capital Management's biggest Q2 2015 reduction was Biogen, cutting an estimated $215M.
  • Marsico Capital Management fully exited Gilead Sciences in Q2 2015, selling an estimated $265M.
  • Marsico Capital Management's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2015.
  • Marsico Capital Management opened 17 new positions and closed 13 in Q2 2015.
  • Marsico Capital Management's portfolio value fell 4.5% quarter-over-quarter to $11.3B.

Based on Marsico Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.